Biostarks recently celebrated its newest office opening, Biostarks Labs Singapore, according to a press release.
The company plans to begin distributing its first set of kits during the second quarter of 2023.
"Biostarks Labs Singapore's main goal is to contract with public and private partners in the APAC region to best serve the interests of the regional population. Biostarks' technology measures the potential deficiencies of groups/certain biomarkers and provides solutions and recommendations to compensate for and reduce said deficiencies," executive chairman of the company, Francois Marland, said.
Serving as the company’s third branch, news of the new establishment follows a similar launch of Biostarks Europe, based in Geneva, Switzerland. It is now a 100% subsidiary of Biostarks Labs U.S. Inc.
The launch follows a similar global partnership deal with Ironman Global series, making Biostarks the first preventative health company to establish an international presence.
The digital health company offers remote blood test kits, which are credited with easy, cost-effective and global access.
“A proprietary breakthrough technology that was once available only to elite athletes is now accessible to all, allowing consumers to make informed decisions about their health and wellness,” a recent press release states.